Literature DB >> 10421759

Rapid fluorescence-based reporter-gene assays to evaluate the cytotoxicity and antitumor drug potential of platinum complexes.

K E Sandman1, S S Marla, G Zlokarnik, S J Lippard.   

Abstract

BACKGROUND: The need for new platinum antitumor drugs is underscored by the usefulness of cisplatin and carboplatin in chemotherapy and the resistance of many tumors to these compounds. Combinatorial chemistry could aid in the search for cisplatin analogs if fast, high-throughput assays were available. Our goal was to develop rapid cell-based assays suitable for high-throughput screening that accurately predict the cytotoxicity of platinum complexes. We examined the effects of platinum complexes and other agents on reporter-gene expression in cancer cells.
RESULTS: HeLa Tet-On cells with inducible enhanced green fluorescent protein (EGFP) were prepared. Cisplatin and other cis-disubstituted platinum complexes inhibited EGFP expression, with a strong positive correlation between EGFP inhibition and cytotoxicity. By contrast, trans-[Pt(NH(3))(2)Cl(2)], other trans-platinum complexes, methyl methanesulfonate or heat shock stimulated EGFP expression. Northern and nuclear run-on analyses revealed that the changes in EGFP expression were at the level of transcription. In another reporter-gene assay in Jurkat cells, cisplatin, but not trans-[Pt(NH(3))(2)Cl(2)] or K(2)[PtCl(4)], inhibited beta-lactamase expression, as measured by hydrolysis of the fluorescent substrate CCF2.
CONCLUSIONS: The EGFP results indicate that cytotoxic stress enhances transcription from the inducible promoter, whereas compounds able to form the 1,2-intrastrand platinum-DNA cross-links repress transcription. Both fluorescence-based reporter-gene assays afford promising new approaches to platinum anticancer drug discovery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421759     DOI: 10.1016/S1074-5521(99)80086-6

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  8 in total

1.  X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct.

Authors:  Dong Wang; Guangyu Zhu; Xuhui Huang; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

2.  Photochemical and Photobiological Activity of Ru(II) Homoleptic and Heteroleptic Complexes Containing Methylated Bipyridyl-type Ligands.

Authors:  Lars Kohler; Leona Nease; Pascal Vo; Jenna Garofolo; David K Heidary; Randolph P Thummel; Edith C Glazer
Journal:  Inorg Chem       Date:  2017-09-26       Impact factor: 5.165

3.  Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.

Authors:  Guangyu Zhu; MyatNoeZin Myint; Wee Han Ang; Lina Song; Stephen J Lippard
Journal:  Cancer Res       Date:  2011-12-16       Impact factor: 12.701

4.  Anti-Prostate Cancer Activity of 8-Hydroxyquinoline-2-Carboxaldehyde-Thiosemicarbazide Copper Complexes by Fluorescent Microscopic Imaging.

Authors:  Fang Xie; Fangyu Peng
Journal:  J Fluoresc       Date:  2017-06-26       Impact factor: 2.217

5.  Anticancer Activity of Copper Complex of (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic Acid and 3-Rhodaninepropionic Acid on Prostate and Breast Cancer Cells by Fluorescent Microscopic Imaging.

Authors:  Fang Xie; Fangyu Peng
Journal:  J Fluoresc       Date:  2017-09-09       Impact factor: 2.217

Review 6.  Inhibition of transcription by platinum antitumor compounds.

Authors:  Ryan C Todd; Stephen J Lippard
Journal:  Metallomics       Date:  2009       Impact factor: 4.526

7.  Bacterial Cytological Profiling Reveals the Mechanism of Action of Anticancer Metal Complexes.

Authors:  Yang Sun; David K Heidary; Zhihui Zhang; Christopher I Richards; Edith C Glazer
Journal:  Mol Pharm       Date:  2018-06-30       Impact factor: 4.939

8.  Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression.

Authors:  Toshifumi Kishimoto; Yuko Yoshikawa; Kenichi Yoshikawa; Seiji Komeda
Journal:  Int J Mol Sci       Date:  2019-12-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.